Stephen T. Isaacs, President and CEO at ADURO BIOTECH, INC. (ADRO), sold 118,468 shares at $7.95 ($1.0M) on 2018-03-08, disclosed to the SEC on 2018-03-09.
Open-market sale of $1.0M ADRO by President and CEO. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $7.95 | 25,634 | $204K | 20.0% |
| 2 | $8.59 | 25,812 | $222K | 21.8% |
| 3 | $8.59 | 25,812 | $222K | 21.8% |
| 4 | $9.01 | 20,605 | $186K | 18.2% |
| 5 | $9.01 | 20,605 | $186K | 18.2% |
| Total | $8.60 avg | 118,468 |
| $1.0M |
| 100% |
| Filing → |
| ADRO | SELL | 2019-09-17 | $41K | — | Filing → |
| ADRO | SELL | 2018-12-14 | $17K | — | Filing → |
| ADRO | SELL | 2018-09-14 | $314K | — | Filing → |